The mechanisms of antihyperalgesic effect of topiramate in a rat model of inflammatory hyperalgesia

Fundamental and Clinical Pharmacology

Volumn 27, Issue 3, 2013, Pages 319-328

  Paranos, Sonja Lj ^a   Tomić, Maja A ^a   Micov, Ana M ^a   Stepanović Petrović, Radica M ^a  

^a UNIVERSITY OF BELGRADE   (Serbia)

Author keywords

2 adrenoceptors; GABAA receptors; Inflammatory hyperalgesia; Opioid receptors; Topiramate

Indexed keywords

4 AMINOBUTYRIC ACID RECEPTOR; ADRENERGIC RECEPTOR; BICUCULLINE; CARRAGEENAN; NALOXONE; OPIATE RECEPTOR; TOPIRAMATE; YOHIMBINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINOCICEPTION; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; HYPERALGESIA; INFLAMMATORY PAIN; MALE; NONHUMAN; PRESSURE; PRIORITY JOURNAL; RAT; SYSTEMIC THERAPY;

ANALGESICS; ANIMALS; BICUCULLINE; CARRAGEENAN; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; FRUCTOSE; HYPERALGESIA; INFLAMMATION; MALE; NALOXONE; RATS; RATS, WISTAR; RECEPTORS, ADRENERGIC, ALPHA-2; RECEPTORS, GABA-A; RECEPTORS, OPIOID; YOHIMBINE;

EID: 84877816815     PISSN: 07673981     EISSN: 14728206     Source Type: Journal    
DOI: 10.1111/j.1472-8206.2011.01018.x     Document Type: Article

References (38)

1. Chong M.S., Libretto S.E.The rationale and use of topiramate for treating neuropathic pain. Clin. J. Pain (2003) 19 59-68.
2. Lovell B.V., Marmura M.J.New therapeutic developments in chronic migraine. Curr. Opin. Neurol. (2010) 23 254-258.
3. Bischofs S., Zelenka M., Sommer C.Evaluation of topiramate as an anti hyperalgesic and neuroprotective agent in the peripheral nervous system. J. Peripher. Nerv. Syst. (2004) 9 70-78.
4. Benoliel R., Tal M., Eliav E.Effects of topiramate on the chronic constriction injury model in the rat. J. Pain. (2006) 7 878-883.
5. Xiao W., Naso L., Bennett G.J.Experimental studies of potential analgesics for the treatment of chemotherapy-evoked painful peripheral neuropathies. Pain Med. (2008) 9 505-517.
6. Lopes L.S., Pereira S.S., Silva L.L. et al.Antinociceptive effect of topiramate in models of acute pain and diabetic neuropathy in rodents. Life Sci. (2009) 84 105-110.
7. Stepanović-Petrović R.M., Tomić M.A., Vučković S.M. et al.The antinociceptive effects of anticonvulsants in a mouse visceral pain model. Anesth. Analg. (2008) 106 1897-1903.
8. Nakamura-Craig M., Follenfant R.L.Effect of lamotrigine in the acute and chronic hyperalgesia induced by PGE2 and in the chronic hyperalgesia in rats with streptozotocin-induced diabetes. Pain (1995) 63 33-37.
9. Field M.J., Oles R.J., Lewis A.S., McCleary S., Hughes J., Singh L.Gabapentin (neurontin) and S-(+)-3-isobutylgaba represent a novel class of selective antihyperalgesic agents. Br. J. Pharmacol. (1997) 12 1513-1522.
10. Tomić M.A., Vučković S.M., Stepanović-Petrović R.M., Ugrešić N., Prostran M.S., Bošković B.The anti-hyperalgesic effects of carbamazepine and oxcarbazepine are attenuated by treatment with adenosine receptor antagonists. Pain (2004) 111 253-260.
11. Vučković S.M., Tomić M.A., Stepanović-Petrović R.M., Ugrešić N., Prostran M.S., Bošković B.The effects of alpha2-adrenoceptor agents on anti-hyperalgesic effects of carbamazepine and oxcarbazepine in a rat model of inflammatory pain. Pain (2006) 125 10-19.
12. Munro G., Ahring P.K., Mirza N.R.Developing analgesics by enhancing spinal inhibition after injury: GABAA receptor subtypes as novel targets. Trends Pharmacol. Sci. (2009) 30 453-459.
13. Simjee S.U., Pleuvry B.J., Coulthard P.Modulation of the gait deficit in arthritic rats by infusions of muscimol and bicuculline. Pain (2004) 109 453-460.
14. Yano S., Suzuki Y., Yuzurihara M. et al.Antinociceptive effect of methyleugenol on formalin-induced hyperalgesia in mice. Eur. J. Pharmacol. (2006) 553 99-103.
15. Pol O.The involvement of the nitric oxide in the effects and expression of opioid receptors during peripheral inflammation. Curr. Med. Chem. (2007) 14 1945-1955.
16. Vanegas H., Schaible H.G.Descending control of persistent pain: inhibitory or facilitatory?Brain Res. Brain Res. Rev. (2004) 46 295-309.
17. Buerkle H., Schäpsmeier M., Bantel C., Marcus M.A., Wüsten R., Van Aken H.Thermal and mechanical antinociceptive action of spinal vs peripherally administered clonidine in the rat inflamed knee joint model. Br. J. Anaesth. (1999) 83 436-441.
18. Zimmermann M.Ethical guidelines for investigations of experimental pain in conscious animals. Pain (1983) 6 109-110.
19. Randall L.O., Selitto J.J.A method for measurement of analgesic activity on inflamed tissue. Arch. Int. Pharmacodyn. Ther. (1957) 111 409-419.
20. Morris C.J.Carrageenan-induced paw edema in the rat and mouse, in: Winyard P.G., Willoughby D.A. (Eds), Inflammation protocols (methods in molecular biology), Humana Press Inc, Totowa, New Jersey, USA, 2003, pp. 115-123.
21. Tallarida R.J.Drug synergism and dose-effect data analysis, 1st edn, Chapman & Hall/CRC, Boca Raton, London, New York, Washington, 2000.
22. Dawson-Saunders B., Trapp R.G.Basic & clinical biostatistics, 2nd edn, Appleton & Lange, Norwalk, 1994.
23. Shannon H.E., Eberle E.L., Peters S.C.Comparison of the effects of anticonvulsant drugs with diverse mechanisms of action in the formalin test in rats. Neuropharmacology (2005) 48 1012-1020.
24. Vissers K.C.P., Geenen F., Biermans R., Meert T.F.Pharmacological correlation between the formalin test and the neuropathic pain behavior in different species with chronic constriction injury. Pharmacol. Biochem. Behav. (2006) 84 479-486.
25. Shank R.P., Gardocki J.F., Vaught J.L.Topiramate: preclinical evaluation of a structurally novel anticonvulsant. Epilepsia (1994) 35 450-460.
26. Gordey M., DeLorey T.M., Olsen R.W.Differential sensitivity of Recombinant GABA(A) receptors expressed in Xenopus oocytes to modulation by topiramate. Epilepsia (2000) 41 S25-S29.
27. White H.S., Brown S.D., Woodhead J.H., Skeen G.A., Wolf H.H.Topiramate modulates GABA-evoked currents in murine cortical neurons by nonbenzodiazepine mechanism. Epilepsia (2000) 41 S17-S20.
28. Perucca E.A pharmacological and clinical review on topiramate, a new antiepileptic drug. Pharmacol. Res. (1997) 35 241-256.
29. Sills G.J., Leach J.P., Kipltarick W.S., Frase C.M., Thompson G.G., Brodie M.J.Concentration-effect studies with topiramate on selected enzymes and intermediates of the GABA shunt. Epilepsia (2000) 41 S30-S34.
30. Edvinsson L., Linde M.New drugs in migraine treatment and prophylaxis: telcagepant and topiramate. Lancet (2010) 376 645-655.
31. Kuzniecky R., Pan J., MArtin R, Gilliam F., Faught E., Hetherington H.Modulation of cerebral GABA by topiramate, lamotrigine, and gabapentin in healthy adults. Neurology (2002) 58 368-372.
32. Carlton S.M., Zhou S., Coggeshall R.E.Peripheral GABA(A) receptors: evidence for peripheral primary afferent depolarization. Neuroscience (1999) 93 713-722.
33. Sawynok J.Topical and peripherally acting analgesics. Pharmacol. Rev. (2003) 55 1-20.
34. Shank RP, Gardocki JF, Streeter AJ, Maryanoff BE.An overview of the preclinical aspects of topiramate: pharmacology, pharmacokinetics, and mechanism of action. Epilepsia (2000) 41(Suppl 1) S3-S9.
35. Martella G., Costa C., Pisani A., Cupini L.M., Bernardi G., Calabresi P.Antiepileptic drugs on calcium currents recorded from cortical and PAG neurons: therapeutic implications for migraine. Cephalalgia (2008) 28 1315-1326.
36. Yaksh T.L., Wallace M.S.Opioids, analgesia, and pain management, in: Brunton L.L., Chabner B.A., Knollmann B.C. (Eds), Goodman & Gilman's The pharmacological basis of therapeutics, 12th edn, McGraw-Hill, New York, 2011, pp. 481-525.
37. Oda A., Iida H., Tanahashi S., Osawa Y., Yamaguchi S., Dohi S.Effects of alpha2-adrenoceptor agonists on tetrodotoxin-resistant Na+ channels in rat dorsal root ganglion neurons. Eur. J. Anaesthesiol. (2007) 24 934-941.
38. Jänig W, Levine JD, Michaelis M.Interactions of sympathetic and primary afferent neurons following nerve injury and tissue trauma. Prog. Brain Res. (1996) 113 161-184.